Italy vs Portugal: Cause of death, by non-communicable diseases, ages 60+, male
Italy
80.7%
in 2021
Portugal
80.3%
in 2021
Italy rank
37th
Portugal rank
40th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Italy
- Portugal
How they compare
Italy currently reports 80.7% against 80.3% in Portugal, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Italy ahead.
Italy ranks 37th and Portugal ranks 40th of 185 countries.
Across the 3 decades both report, Italy averaged higher in 2 and Portugal in 1.
Head to head by decade
| Decade | Italy | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.0% | 89.6% | 4.4% | Italy |
| 2010s | 92.4% | 87.6% | 4.8% | Italy |
| 2020s | 80.1% | 80.9% | 0.8% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Italy or Portugal?
- Italy, at 80.7% against 80.3% in Portugal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Italy and Portugal?
- 0.4%, with Italy ahead.
- How many years of comparable data are there for Italy and Portugal?
- 6 years are reported by both, from 2000 to 2021.
- How do Italy and Portugal rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Italy ranks 37th and Portugal ranks 40th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.